Holdings
Rock Springs Capital Management LP
As of Jun 30, 2026, Rock Springs Capital Management LP reported 95 positions worth US$1.91B. Largest: Revolution Medicines, Inc., Travere Therapeutics, Inc. and Eli Lilly And Company. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 1.11M | US$207M | −104K | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 2.18M | US$124M | +701K | Jun 30, 2026 |
| Eli Lilly And Company | 98,700 | US$118M | no change | Jun 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 175K | US$94M | +4,000 | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 798K | US$93.4M | −13,149 | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 693K | US$76.9M | +2,850 | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 453K | US$52M | −43,715 | Jun 30, 2026 |
| Argenx Se | 52,750 | US$48.9M | −45,750 | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 684K | US$41.3M | −79,113 | Jun 30, 2026 |
| Scholar Rock Holding Corporation | 715K | US$39.3M | −24,364 | Jun 30, 2026 |